PROFITELLIGENCE/Guest access
!
Financial disclaimer

Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.

Legal agreement

By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.

i
Guest mode

You're browsing as a guest. Some features like watchlists and alerts require a free account.

--:--:--
Guest mode— viewing ISRG. Sign up free to access all symbols.Sign up
ISRG logo

ISRG

Intuitive Surgical, Inc.

HealthcareMedical Instruments & Supplies

Price performance

Sep 18, 2026
$393.33
+$9.79+2.55%
1M
-1.10%
3M
-3.31%
YTD
-30.01%
vs SPY
+5.15%
30d range
345–405
Volatility
32.31%
Signals
Price chart

Company activity

25 events
Company activity
TimeTickerTypeEventQtyPriceValue
07/27ISRG8-KIntuitive Surgical Updates Corporate Governance with Bylaw Amendments
07/16ISRG8-KIntuitive Surgical Reports Strong Q2 2026 Financial Results
05/28ISRG8-KIntuitive Surgical Appoints New Chief Commercial and Marketing Officer
05/04ISRG8-KIntuitive Surgical Approves Amended Incentive Award Plan and Increases Stock Repurchase Program
04/21ISRG8-KIntuitive Surgical Reports Strong Q1 2026 Financial Results and Outlook
03/02ISRG8-KIntuitive Surgical Completes Acquisition of da Vinci and Ion Distribution Business in Europe
01/22ISRG8-KIntuitive Surgical Reports Strong Q4 2025 Financial Results
01/14ISRG8-KIntuitive Surgical Announces Strong 2025 Financial Performance
12/18/25ISRG8-KIntuitive Surgical's Chief Digital Officer Transitions to New Role
10/21/25ISRG8-KIntuitive Surgical Announces Quarterly Financial Results
07/22/25ISRG8-KIntuitive Surgical Announces Financial Results for Q2 2025
05/15/25ISRG8-KIntuitive Surgical Announces CEO Transition with Dave Rosa Promotion
05/05/25ISRG8-KIntuitive Surgical Announces Approval of Amended Incentive Plan and Stock Repurchase Program
04/22/25ISRG8-KIntuitive Surgical Announces Q1 2025 Financial Results
01/23/25ISRG8-KIntuitive Surgical to Acquire da Vinci Distribution in Southern Europe
01/15/25ISRG8-KIntuitive Surgical Reports Preliminary Q4 and Full Year 2024 Financial Results
01/06/25ISRG8-KIntuitive Surgical Promotes Key Executives
10/17/24ISRG8-KIntuitive Surgical Announces Financial Results for Q3 2024
07/25/24ISRG8-KIntuitive Appoints President to Board of Directors
07/18/24ISRG8-KIntuitive Surgical Reports Strong Q2 2024 Financial Results
04/30/24ISRG8-KIntuitive Surgical Announces New Board Appointments and Proposal Outcomes
04/18/24ISRG8-KIntuitive Surgical Announces Quarterly Financial Results
03/14/24ISRG8-KIntuitive Surgical Announces FDA Clearance for da Vinci 5
01/23/24ISRG8-KIntuitive Surgical Announces Q4 2023 Financial Results
01/09/24ISRG8-KIntuitive Surgical Reports Strong Preliminary 2023 Results

ISRG filing record

Intuitive Surgical, Inc. (ISRG): 25 8-K filings summarized, the most recent on Jul 27, 2026.

What the 8-K filings said

  1. Jul 27, 2026 · high impact

    On July 23, 2026, Intuitive Surgical, Inc. amended its Amended and Restated Bylaws to enhance corporate governance, including changes to shareholder voting rules, proxy solicitation procedures, and disclosure requirements for shareholder nominations and proposals. These amendments aim to streamline the nomination…

    Intuitive Surgical Updates Corporate Governance with Bylaw Amendments
  2. Jul 16, 2026 · medium impact

    Intuitive Surgical, Inc. announced its financial results for the quarter ended June 30, 2026, reporting a 19% increase in revenue to $2.89 billion. The company saw a 16% growth in worldwide procedures, with da Vinci procedures up 15% and Ion procedures up 36%. Net income attributable to Intuitive Surgical, Inc. was…

    Intuitive Surgical Reports Strong Q2 2026 Financial Results
  3. May 28, 2026 · high impact

    Intuitive Surgical, Inc. announced on May 28, 2026, that Taylor Patton will succeed Henry L. Charlton as the Company's Chief Commercial and Marketing Officer, effective July 1, 2026. Charlton will transition to the role of Senior Vice President of Global Business Operations. Patton, with nearly two decades of…

    Intuitive Surgical Appoints New Chief Commercial and Marketing Officer
  4. May 4, 2026 · medium impact

    Intuitive Surgical, Inc. announced that its stockholders approved the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan at the Annual Meeting held on April 30, 2026. The amendment increases the number of shares reserved for issuance under the plan and extends its term.…

    Intuitive Surgical Approves Amended Incentive Award Plan and Increases Stock Repurchase Program
  5. Apr 21, 2026 · high impact

    Intuitive Surgical, Inc. announced its financial results for the first quarter of 2026, reporting a 23% increase in revenue to $2.77 billion. The company saw growth in worldwide procedures, with da Vinci procedures up 16% and Ion procedures up 39%. The installed base of da Vinci systems grew 12% to 11,395 systems, and…

    Intuitive Surgical Reports Strong Q1 2026 Financial Results and Outlook

SEC filings in the last five years

  • 38 Form 8-K
  • 13 Form 10-Q
  • 5 Form 10-K